FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Goals: Guidance for Industry and Food and Drug Administration Staff

Information

Type

Guidance

Regulated products

Biologics, Medical Devices

Topics

Premarket

Published

October 3, 2022

Last updated

October 6, 2022

Description

This document provides guidance for the FDA and industry on the impact of premarket approval applications on review timelines and goals.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed